Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSepio Capital, LP
Latest Disclosed Ownership12,993 shares
Latest Disclosed Value $ 1,984,669
Sepio Capital, LP reports 7.37% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Sepio Capital, LP filed a 13F-HR form disclosing ownership of 12,993 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,669,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 14,027 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -7.37% during the quarter. The current value of the position is $1,572,153 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,993 -1,034 -7.37 1,985 2.64 0.1078
2026-02-12 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 14,027 476 3.51 1,934 11.28 0.1058
2025-11-13 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,551 356 2.70 1,738 8.83 0.1028
2025-08-13 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 13,195 16 0.12 1,597 8.65 0.1136
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,179 -489 -3.58 1,469 10.45 0.1163
2025-02-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 13,668 -19 -0.14 1,330 -15.50 0.1064
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,687 -133 -0.96 1,574 7.00 0.1226
2024-08-15 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 13,820 -32 -0.23 1,471 9.86 0.1349
2024-05-15 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,852 -1,257 -8.32 1,340 -12.20 0.1149
2024-02-09 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 15,109 -2,071 -12.05 1,526 -12.81 0.1282
2023-11-08 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 17,180 939 5.78 1,750 6.78 0.1511
2023-08-08 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 16,241 -649 -3.84 1,638 5.47 0.1330
2023-05-10 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 16,890 -17,250 -50.53 1,554 -49.85 0.1433
2023-02-03 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 34,140 -12,208 -26.34 3,097 -12.09 0.2676
2022-10-28 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 46,348 -2,751 -5.60 3,523 -15.11 0.3497
2022-07-26 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 49,099 -2,870 -5.52 4,150 -8.99 0.4169
2022-05-09 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 51,969 -5,703 -9.89 4,560 -9.61 0.4000
2022-01-25 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 57,672 -1,199 -2.04 5,045 4.80 0.3727
2021-11-03 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 58,871 689 1.18 4,814 -9.32 0.3968
2021-07-29 2021-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 58,182 -1,463 -2.45 5,309 4.14 0.4374
2021-07-26 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 58,182 -1,463 5,309 0.4577
2021-05-10 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 59,645 59,645 5,098 0.4696
2019-10-25 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -24,437 -100.00 0 -100.00
2019-08-08 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 24,437 -179 -0.73 2,231 -5.75 0.3013
2019-06-21 2019-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 24,616 -3,216 -11.56 2,367 -0.88 0.3194
2019-05-14 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 24,616 -3,216 2,367 0.3500
2019-02-13 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 27,832 27,832 2,388 0.1736
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.